Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.9K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

39.9K
Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
39.9K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.8K
What are Viruses?00:50

What are Viruses?

128.0K
Overview
128.0K
Elevation of Intermediate Points on Vertical Curves01:20

Elevation of Intermediate Points on Vertical Curves

285
Vertical curves are essential in roadway design because they provide smooth transitions between varying roadway grades. Designing vertical curves involves calculating intermediate elevations and identifying the curve's highest or lowest point, which is essential for optimal roadway performance.Intermediate elevations on a vertical curve are determined using the tangent offset method. This method considers the initial elevation at the start of the curve, the grades, and the curve's geometry. The...
285
Source And Potency Of Stem Cells01:27

Source And Potency Of Stem Cells

6.3K
Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emerging Biomaterials Deliver Heat Shock Protein 90 Inhibitors to Enhance Therapeutic Efficacy in Cancer Therapy.

Acta biomaterialia·2026
Same author

Tumor acid-triggered sericin prodrug colloidal system for enhanced photodynamic and ferroptosis therapy of breast cancer.

Materials today. Bio·2026
Same author

Psychosocial predictors of chemotherapy-induced nausea and vomiting among chemotherapy-naïve cancer patients: a prospective multicenter cohort study.

Journal of cancer survivorship : research and practice·2026
Same author

Tailored Biomaterials Induce Tertiary Lymphoid Structures for Boosting Cancer Immunotherapy.

ACS nano·2026
Same author

Zwitterionic Lipid Nanotherapeutics from Mulberry for Oral Treatment of Diabetic Colitis.

ACS nano·2026
Same author

Orchestrating mast cell for cancer immunotherapy.

International immunopharmacology·2026

Related Experiment Video

Updated: Jan 29, 2026

Ex Vivo Infection of Live Tissue with Oncolytic Viruses
12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

13.3K

Innovative Biomaterials Synergize Oncolytic Virus for Elevating Tumor Immunotherapy Potency.

Jiaxue Wen1, Shu-Jin Li2, Ruohan Xiao1

  • 1Key Laboratory of Luminescence Analysis and Molecular Sensing, Ministry of Education, School of Materials and Energy, College of Sericulture, Textile and Biomass Sciences, Southwest University, Chongqing, China.

Advanced Materials (Deerfield Beach, Fla.)
|January 28, 2026
PubMed
Summary

Biomaterials enhance oncolytic virus (OV) therapy for cancer by improving viral delivery and overcoming tumor microenvironment challenges. This combination strategy shows promise for more effective cancer immunotherapy.

Keywords:
BiomaterialsDrug deliveryImmunotherapyOncolytic virusTumor microenvironment

More Related Videos

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
06:14

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

7.4K
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

9.9K

Related Experiment Videos

Last Updated: Jan 29, 2026

Ex Vivo Infection of Live Tissue with Oncolytic Viruses
12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

13.3K
Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
06:14

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

7.4K
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

9.9K

Area of Science:

  • Biomedical Engineering
  • Immunology
  • Materials Science

Background:

  • Oncolytic viruses (OVs) show promise in cancer immunotherapy by selectively targeting tumor cells and stimulating immune responses.
  • OV monotherapy faces challenges like poor delivery, immune suppression within tumors, and rapid clearance.
  • Biomaterials offer innovative solutions to overcome these limitations in virotherapy.

Purpose of the Study:

  • To review the synergistic combination of biomaterials with oncolytic viruses (OVs) for enhanced cancer immunotherapy.
  • To highlight nanomaterial-based and cell-derived biomaterials as key delivery systems.
  • To discuss the design, mechanisms, and applications of biomimetic virus-like nanoparticles.

Main Methods:

  • Systematic review of literature on biomaterial-OV combinations in cancer therapy.
  • Categorization of biomaterials into nanomaterial-based carriers and cell-derived materials.
  • Critical discussion of biomimetic virus-like nanoparticles, their principles, mechanisms, and applications.

Main Results:

  • Biomaterial delivery systems protect OVs from immune clearance, enable targeted delivery, and control viral release.
  • Functionalized biomaterials can modulate the immune system and remodel the tumor microenvironment.
  • Biomimetic virus-like nanoparticles represent a significant advancement in this field.

Conclusions:

  • Combining biomaterials with OVs offers a powerful strategy to enhance cancer immunotherapy.
  • Intelligent biomaterial design is crucial for overcoming OV therapy limitations.
  • This approach holds significant potential for clinical translation in cancer treatment.